PRO283698

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO283698, covering 2010-12-01 to 2010-12-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis [Phase 1]